Alzheimer’s disease is one of the most serious brain disorders in the world. It slowly damages memory, thinking, and daily functioning.
Millions of people live with this condition, and it affects not only patients but also their families.
While current treatments can slow the disease in some cases, they do not restore lost memory. Because of this, scientists are searching for new ways to repair the brain.
A new study from UCLA Health has discovered a promising molecule that may help restore memory, at least in mice. This molecule, called DDL-920, works in a very different way from existing Alzheimer’s treatments. Instead of removing harmful substances from the brain, it aims to help the brain’s memory system start working again.
The research was led by Dr. Istvan Mody and Dr. Varghese John. Their team focused on a key problem in Alzheimer’s disease: the breakdown of communication between brain cells. In a healthy brain, nerve cells send signals to each other using electrical activity. These signals help control thinking, memory, and behavior.
One important type of brain activity is called gamma oscillations. These are fast brain waves that help with memory and attention. For example, they are involved when you try to remember a phone number or follow a conversation. In people with Alzheimer’s disease, these brain waves are often weaker, which may explain why memory becomes impaired.
In the past, scientists tried to improve gamma oscillations using outside methods such as sound or magnetic stimulation. These approaches helped reduce harmful plaques in the brain, but they did not improve memory very much. This suggested that simply removing plaques may not be enough.
Dr. Mody and his team decided to try a new idea. They wanted to boost these brain waves from inside the brain using a drug. To do this, they studied special brain cells called parvalbumin interneurons. These cells are important for creating gamma oscillations.
In Alzheimer’s disease, these neurons do not work properly. One reason is a chemical called GABA, which normally helps control brain activity. In this case, GABA acts like a brake, preventing these neurons from becoming active enough. As a result, gamma oscillations become weak.
The researchers developed DDL-920 to solve this problem. The molecule blocks the effect of GABA on these neurons, allowing them to become more active. This helps restore stronger gamma oscillations, which may improve memory.
To test their idea, the scientists used mice that were genetically designed to show Alzheimer’s-like symptoms. These mice often struggle with memory tasks. The researchers used a test called the Barnes maze, where mice must find a hidden escape hole using visual clues.
Before treatment, the Alzheimer’s mice had difficulty remembering where the escape hole was. After receiving DDL-920 for two weeks, their performance improved greatly. In fact, they performed almost as well as healthy mice, showing that their memory had improved.
Another important finding was that the treated mice did not show harmful side effects during the study. This suggests that the treatment may be safe, at least in animals. However, the researchers stress that much more testing is needed before it can be used in humans.
This discovery is exciting because it offers a completely new way to treat Alzheimer’s disease. Instead of focusing only on removing plaques, it aims to repair how the brain works. If future studies show similar results in humans, this approach could lead to better treatments that not only slow the disease but also improve memory.
The researchers also believe that this method might help with other conditions that involve changes in brain activity, such as depression, schizophrenia, and autism.
Even though this research is still in the early stages, it gives hope to millions of people affected by Alzheimer’s disease. It shows that scientists are making progress and exploring new ideas that could one day lead to real improvements in brain health.
The findings of this study were published in the journal Proceedings of the National Academy of Sciences (PNAS). As research continues, scientists hope to move from animal studies to human trials and eventually develop safe and effective treatments.
For now, this study reminds us that the brain is complex, and solving diseases like Alzheimer’s will require new and creative approaches. The possibility of restoring memory, rather than just slowing its loss, represents an important step forward.
If you care about brain health, please read studies about vitamin D deficiency linked to Alzheimer’s and vascular dementia, and higher magnesium intake could help benefit brain health.
For more information about brain health, please see recent studies about antioxidants that could help reduce dementia risk, and coconut oil could help improve cognitive function in Alzheimer’s.
Copyright © 2026 Knowridge Science Report. All rights reserved.
